Evidence map›Paper›PMID 22810271›Full record

ArticleImmunogenetics2012

Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccine.

Jagadish Chandrabose Sundaramurthi, Soumya Swaminathan, Luke Elizabeth Hanna

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jagadish Chandrabose SundaramurthiDivision of Biomedical Informatics, Department of Clinical Research, National Institute for Research in Tuberculosis (Formerly Tuberculosis Research Centre), (ICMR), 1, Sathiyamoorthy Road, Chetpet, Chennai, 600031, Tamil Nadu, India.
Soumya Swaminathan
Luke Elizabeth Hanna

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Earlier studies have identified a large number of immunogenic epitopes in HIV-1. Efforts are required to prioritize these epitopes in order to identify the best candidates for formulating an effective multi-epitope vaccine for HIV. We modeled 155 known cytotoxic T lymphocyte epitopes of HIV-1 subtype C on the 3D structure of HLA-A*0201, HLA-B*2705, and HLA-B*5101 using MODPROPEP, as these alleles are known to be associated with resistance to HIV/slow progression to AIDS. Thirty-six epitopes were identified to bind to all the three HLA alleles with better binding affinity than the control peptides complexed with each HLA allele but not to any of the HLA alleles reported to be associated with susceptibility to HIV infection/rapid progression to disease. As increase in stability of the epitope-HLA complex results in increased immunogenicity, the short-listed epitopes could be suitable candidates for vaccine development. Twenty of the 36 epitopes were polyfunctional in nature adding to their immunological relevance for vaccine design. Further, 9 of the 20 polyfunctional epitopes were found to bind to all three resistance-associated HLA alleles using an additional method, adding worth to their potential as candidates for a vaccine formulation for HIV-1C.

Indexed as

Acquired Immunodeficiency SyndromeAIDS VaccinesEpitope MappingEpitopes, T-LymphocyteHIV-1HIV InfectionsHLA AntigensHumansImmunity, CellularPeptide FragmentsAIDS VaccinesEpitopes, T-LymphocyteHLA AntigensPeptide Fragments

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.